← Browse by Condition
Medical Condition

melanoma stage iii or iv

Total Trials
1
Recruiting Now
1
Trial Phases
Various
NCT06784778
Recruiting

Observational Study of Patients With Advanced Melanoma (Skin Cancer) to Assess if IOpener®-Melanoma Test Can Predict Response to Immunotherapy.

Enrollment
196 pts
Location
Germany
Sponsor
Pamgene International B.V.
View Trial →